NEWS IN BRIEF
11-Dec-2018 By Staff Reporter
The FDA provided Fresenius Kabi helped with a Drug Shortage Assistance Award for providing IV saline solution during the Puerto Rico hurricane crisis.
30-Jan-2018 By Dan Stanton
AbbVie plans to invest around $2.5bn (€2bn) into its US network over the next five years.
18-Oct-2017 By Dan Stanton
Back-up generators and secondary manufacturing sites limited the supply and financial impact of Hurricane Maria across J&J’s Puerto Rican pharma facilities, the firm says.
26-Sep-2017 By Gareth Macdonald
Communication difficulties are hampering drug industry efforts to assess damage to manufacturing operations caused by the hurricane that struck Puerto Rico last week.
07-Feb-2017 By Melissa Fassbender
DHL Global Forwarding is opening four new temperature-controlled storage chambers in San Juan this year after investing nearly $1m in the market in 2016.
18-Jul-2016 By Melissa Fassbender
The cold chain solution company, CSafe, has opened a new San Juan-based service center in conjunction with the launch of its new company, CSafe Puerto Rico LLC.
25-Mar-2015 By Fiona BARRY
AbbVie is investing $30m (€27m) in contract manufacturing facilities in Puerto Rico and plans to create 100 jobs over the next two years.
19-Jan-2015 By Gareth Macdonald
Novartis will close an OTC plant in Puerto Rico by 2019 and transfer manufacturing and packaging actives to sites in the US and facilities operated by Eli Lilly and Virbac.
20-Oct-2014 By Dan Stanton
Eli Lilly is set to close one of its Puerto Rican facilities as patent expirations and a shifting portfolio reduce its need for capacity.
05-Jun-2014 By Dan Stanton
The Puerto Rico Industrial Development Company (PRIDCO) says Actavis’ investment at two facilities is evidence of continued pharma growth, despite a number of recent closures on the island.
10-Dec-2013 By Dan Stanton
Puerto Rico’s drug manufacturing industry has no future unless utility costs and taxes are controlled, according to a regulatory expert.
04-Dec-2013 By Dan Stanton
Pfizer says it is cutting 150 jobs and exiting its packaging operations at an Irish solid oral dose plant in order to increase competitiveness.
25-Nov-2013 By Dan Stanton
Pfizer says it intends to shutter a manufacturing facility in Puerto Rico just days after Merck & Co. announced it was reducing its footprint on the island.
Baxter has announced 400 jobs will be lost at its Puerto Rico plant as it transforms its production to more advanced manufacturing.
12-Jan-2012 By Nick Taylor
The lack of transparency when Puerto Rico imposed a new tax in 2010 may deter drugmakers from expanding on the island, a report found.
FDA sends Mylan Puerto Rico plant a GMP warning letter
23-Nov-2011 By Nick Taylor
The US FDA has sent Mylan a warning letter after inspectors found GMP testing failings at its Puerto Rico facility.
Patheon plans facility exits & capability cuts to improve biz
13-Sep-2011 By Nick Taylor
Patheon is exiting semi-solids, clinical packaging and cutting facilities in response to ‘poor historical performance’.
08-Sep-2011 By Gareth Macdonald
Difficulties transferring know-how from US Pharmas to plants in Puerto Rico may be responsible for the high incidence of manufacturing quality problems on the island, according to the authors of a new study.
FDA oversight of J&J in Puerto Rico is “deeply troubling”
24-May-2011 By Nick Taylor
Fears the US FDA is mismanaging oversight of J&J in Puerto Rico are “deeply troubling”, said a US Congressman.
04-Apr-2011 By Gareth Macdonald
The pharmaceutical manufacturing sector in Puerto Rico will thrive because of and not in spite of changes to the country’s tax and incentive laws according to the Puerto Rico Industrial Development Company (PRIDCO).
New J&J recall insulin pump cartridges
09-Mar-2011 By Gareth Macdonald
US healthcare giant Johnson & Johnson (J&J) has recalled 384,000 of its insulin cartridges on concerns the products could cause serious health problems for diabetics.
B-MS recalls 64m Puerto Rico-made Avalide tablets
17-Jan-2011 By Alexandria Pešić
Bristol-Myers Squibb has recalled 64m tablets of its Avalide blood pressure drug in the US and Puerto Rico over fears it has the potential for reduced efficacy.
Top regulation & enforcement articles of 2010
23-Dec-2010 By Nick Taylor
Regulations and enforcement were big topics yet again in 2010. in-PharmaTechnologist presents five of our most read on the topics, covering starting material quality and overseas inspections.
FDA may be having difficulties in Puerto Rico, says US oversight cmttee
09-Nov-2010 By Gareth Macdonald
The US FDA’s Puerto Rico office may be “having difficulty” monitoring drug manufacturing in the country according to the Congressional Committee on Oversight and Government Reform.
Puerto Rico’s tax cuts to “hinder” offshore biopharma firms
27-Oct-2010 By Alexandria Pešić
PhRMA says a new Puerto Rico law to tax offshore manufacturers will “dramatically hinder” biopharma companies.
Patheon cuts Op loss on PDS gains but manufacturing rev down
14-Sep-2010 By Gareth Macdonald
Patheon says lower Puerto Rico losses helped in fiscal Q3 and reports growing demand for product development services (PDS).
Pfizer to close 8 sites, cut ops at 6 more; 6,000 jobs to go
19-May-2010 By Nick Taylor
Pfizer plans to close eight manufacturing sites and reduce operations at a further six by the end of 2015, leading to 6,000 job losses, as part of its reorganisation after acquiring Wyeth.
04-May-2010 By Nick Taylor
in-PharmaTechnologist presents interactive maps of the pharma average wage, employment levels and number of establishments in the United States.
Blu Pharma plans expansion at new Puerto Rico plant
21-Apr-2010 By Staff Reporter
Capacity at Blu Pharmaceutical’s recently acquired solid dosage production plant in Puerto Rico is set to expand considerable over the next three years according to company president Bill Luster.
Keller buys Lehigh to boost pharma label capacity
02-Feb-2010 By Nick Taylor
Keller-Crescent has acquired Puerto Rico-based Lehigh Press to expand its capacity for producing pharmaceutical labels, inserts and outserts.
Delays, takeover bids and Puerto Rico hurt 09, but Patheon up about 2010
22-Dec-2009 By Gareth Macdonald
Patheon says a slowdown in “outsourcing decision making,” manufacturing problems in Puerto Rico and cost related to JLL’s takeover bid hurt it in fiscal 09.
Patheon cuts capacity in Puerto Rico after years of difficulties
14-Dec-2009 By Gareth Macdonald
Canadian CMO Patheon will consolidate its Puerto Rican activities at its facility in Manati and sell or close its plant in neighbouring Caguas by 2011.
Patheon has “disappointing” Q3 amid problems in Puerto Rico
15-Sep-2009 By Nick Taylor
Patheon has posted “disappointing” Q3 results, with manufacturing difficulties in Puerto Rico, a slowdown in demand for development services and reduced client demand for some products impacting on revenues.
Patheon seeks help to analyse takeover bid
13-Jan-2009 By Phil Taylor
There is still no formal offer on the table for Canadian contract manufacturer Patheon from JLL Patheon Holdings, an investment group which currently owns around 29 per cent of the firm.
Bright times for Puerto Rico as another delivery giant sets up
06-Jan-2009 By Nick Taylor
DHL Global Forwarding has opened a Life Science Competency Center in Carolina, Puerto Rico, which will offer shipping services tailored to the needs of the island’s biotech and pharmaceutical companies.
UPS enters Puerto Rico
13-Nov-2008 By Nick Taylor
UPS is planning on building a new facility in Puerto Rico to help establish a reliable cold-chain delivery service, suggesting a brighter future for the island’s industry.
FDA clears APP’s Barceloneta plant
20-Aug-2008 By Gareth Macdonald
APP Pharmaceuticals, currently the sole supplier of therapeutic heparin vials to the US market, has received FDA approval to manufacture three new formulations of the blood-thinner at its plant in Barceloneta, Puerto Rico.
Patheon gets bigger in high-potency compounds
12-Jun-2008 By Phil Taylor
Patheon gave an update on its restructuring plans in Puerto Rico
yesterday, saying that its plant in Manati will be updated to
provide contract manufacturing of high-potency drugs and controlled
Biovail to close Puerto Rican plants
13-May-2008 By Nick Taylor
Canada-based Biovail has revealed plans to close two Puerto Rican
manufacturing plants and lay off 250 people as it attempts to cut
Patheon's Q1 profits drop as it continues to address Puerto Rico
11-Mar-2008 By Kirsty Barnes
Patheon's first quarter results have continued to be impacted by
its underperforming Puerto Rico operations, although restructuring
plans to remedy the situation are in full swing.
BMS mothballs another Puerto Rico Plant
22-Jan-2008 By Kirsty Barnes
Bristol-Myers Squibb (BMS) has revealed plans to close another site
in Puerto Rico in its latest cost-cutting move.
Patheon reveals plans to tackle Puerto Rico problems
17-Dec-2007 By Kirsty Barnes
Patheon has finally revealed its plans to tackle the ongoing
problems it has been facing with its Puerto Rican operations, which
are draining the firm of profitability.
Puerto Rico pursuing biologic bucks
10-Dec-2007 By Kirsty Barnes
Puerto Rico is making a concerted effort to attract biologic
investment dollars onto the island as it falls foul of a retreat
from pharma firms seeking solid dose manufacturing.
Puerto Rico's problems piling up
21-Nov-2007 By Kirsty Barnes
Pfizer's revelation this week that it plans to slice jobs in Puerto
Rico is the latest in a string of blows for this popular offshore
Patheon continues to show the strain of Puerto Rico
10-Sep-2007 By Kirsty Barnes
Patheon's third quarter results continue to show the strain of the
company's underperforming Puerto Rican operation.
Court sanctions independent trustee for Inyx USA
Outsourcing-Pharma.com special focus
07-Aug-2007 By Kirsty Barnes
A US bankruptcy court judge ruled on Friday that Puerto Rican-based
pharma services firm Inyx USA be put under the control of an
Patheon steps up 'damage control' over Puerto Rico
12-Jun-2007 By Kirsty Barnes
After dismal second quarter results Patheon is stepping up its
resolve for 'damage control' and indicated that further cutbacks at
its problematic Puerto Rico plant are imminent.
Abbott's new biotech plant on the 'Bio Island' good to go
11-Apr-2007 By Anna Lewcock
US pharma Abbott has announced the opening of its new state-of
the-art biologics manufacturing plant in Puerto Rico.
Amgen to use contract manufacturers for expansion
10-Apr-2007 By Kirsty Barnes
Amgen has announced it will increase its reliance on
third-party contract manufacturers as part of its ambitious
Amgen puts the brakes on Irish plant plans
04-Apr-2007 By Anna Lewcock
US biotech Amgen has announced plans to delay construction of its
major new manufacturing plant in Cork, Ireland.